Correlation Between Agilon Health and ArriVent BioPharma,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Agilon Health and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilon Health and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between agilon health and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Agilon Health and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilon Health with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilon Health and ArriVent BioPharma,.

Diversification Opportunities for Agilon Health and ArriVent BioPharma,

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Agilon and ArriVent is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding agilon health and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Agilon Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on agilon health are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Agilon Health i.e., Agilon Health and ArriVent BioPharma, go up and down completely randomly.

Pair Corralation between Agilon Health and ArriVent BioPharma,

Considering the 90-day investment horizon agilon health is expected to generate 2.48 times more return on investment than ArriVent BioPharma,. However, Agilon Health is 2.48 times more volatile than ArriVent BioPharma, Common. It trades about -0.02 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about -0.05 per unit of risk. If you would invest  252.00  in agilon health on August 30, 2024 and sell it today you would lose (41.00) from holding agilon health or give up 16.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

agilon health  vs.  ArriVent BioPharma, Common

 Performance 
       Timeline  
agilon health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days agilon health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
ArriVent BioPharma, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in ArriVent BioPharma, Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent fundamental drivers, ArriVent BioPharma, reported solid returns over the last few months and may actually be approaching a breakup point.

Agilon Health and ArriVent BioPharma, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Agilon Health and ArriVent BioPharma,

The main advantage of trading using opposite Agilon Health and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilon Health position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.
The idea behind agilon health and ArriVent BioPharma, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Insider Screener
Find insiders across different sectors to evaluate their impact on performance